Literature DB >> 15013122

Impact of tricuspid regurgitation on long-term survival.

Jayant Nath1, Elyse Foster, Paul A Heidenreich.   

Abstract

OBJECTIVES: The goal of this study was to examine mortality associated with tricuspid regurgitation (TR) after controlling for left ventricular ejection fraction (LVEF), right ventricular (RV) dilation and dysfunction, and pulmonary artery systolic pressure (PASP).
BACKGROUND: Tricuspid regurgitation is a frequent echocardiographic finding; however, the association with prognosis is unclear.
METHODS: We retrospectively identified 5,223 patients (age 66.5 +/- 12.8 years; predominantly male) undergoing echocardiography at one of three Veterans Affairs Medical Center laboratories over a period of four years. Follow-up data were available for four years (mean 498 +/- 402 days). Kaplan-Meier and proportional hazards methods were used to compare differences in survival among TR grades.
RESULTS: Mortality increased with increasing severity of TR. The one-year survival was 91.7% with no TR, 90.3% with mild TR, 78.9% with moderate TR, and 63.9% with severe TR. Moderate or greater TR was associated with increased mortality regardless of PASP (hazard ratio [HR] 1.31, 95% confidence interval [CI] 1.16 to 1.49 for PASP >40 mm Hg; HR 1.32, 95% CI 1.05 to 1.62 for PASP < or =40 mm Hg) and LVEF (HR 1.49, 95% CI 1.34 to 1.66 for EF <50%; HR 1.54, 95% CI 1.37 to 1.71 for EF > or =50%). When adjusted for age, LVEF, inferior vena cava size, and RV size and function, survival was worse for patients with moderate (HR 1.17, 95% CI 0.96 to 1.42) and severe TR (HR 1.31, 95% CI 1.05 to 1.66) than for those with no TR.
CONCLUSIONS: We conclude that increasing TR severity is associated with worse survival in men regardless of LVEF or pulmonary artery pressure. Severe TR is associated with a poor prognosis, independent of age, biventricular systolic function, RV size, and dilation of the inferior vena cava.

Entities:  

Mesh:

Year:  2004        PMID: 15013122     DOI: 10.1016/j.jacc.2003.09.036

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  226 in total

Review 1.  Tricuspid regurgitation: pathophysiology and management.

Authors:  Rashmi Thapa; Buddhadeb Dawn; Jayant Nath
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 2.  Cardiac surgery 2014 reviewed.

Authors:  Torsten Doenst; Constanze Strüning; Alexandros Moschovas; David Gonzalez-Lopez; Ilija Valchanov; Hristo Kirov; Mahmoud Diab; Gloria Faerber
Journal:  Clin Res Cardiol       Date:  2015-09-24       Impact factor: 5.460

3.  Tricuspid Regurgitation: 2015 Reflections and Re-evaluation.

Authors:  Julia Grapsa; Lawrence Rudski
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-10

4.  Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.

Authors:  Katarzyna Wiechecka; Bartosz Wiechecki; Agnieszka Kapłon-Cieślicka; Agata Tymińska; Monika Budnik; Dominika Hołowaty; Krzysztof Jakubowski; Marcin Michalak; Elżbieta Świętoń; Przemysław Stolarz; Roman Steckiewicz; Marcin Grabowski; Piotr Scisło; Janusz Kochanowski; Krzysztof J Filipiak; Grzegorz Opolski
Journal:  Cardiol J       Date:  2019-06-21       Impact factor: 2.737

5.  When is your surgeon good enough? When do you need a "referent surgeon"?

Authors:  Patrick M McCarthy
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

6.  Improvement of tricuspid regurgitation after transcatheter ASD closure in older patients.

Authors:  L Chen; J Shen; X Shan; F Wang; T Kan; X Tang; X Zhao; Y Qin
Journal:  Herz       Date:  2017-07-19       Impact factor: 1.443

Review 7.  Transcatheter therapies for severe tricuspid regurgitation. Quo vadis?

Authors:  Brunilda Alushi; Kourosh Vathie; Holger Thiele; Alexander Lauten
Journal:  Herz       Date:  2020-05-28       Impact factor: 1.443

8.  Reply: Tricuspid regurgitation severity associated with positioning of RV lead or other etiology assessed by intracardiac echocardiography.

Authors:  Anuj Mediratta; Karima Addetia; Roberto M Lang
Journal:  JACC Cardiovasc Imaging       Date:  2014-12

9.  Predicting Survival From Large Echocardiography and Electronic Health Record Datasets: Optimization With Machine Learning.

Authors:  Manar D Samad; Alvaro Ulloa; Gregory J Wehner; Linyuan Jing; Dustin Hartzel; Christopher W Good; Brent A Williams; Christopher M Haggerty; Brandon K Fornwalt
Journal:  JACC Cardiovasc Imaging       Date:  2018-06-13

10.  Endocardial Device Leads in Patients with Patent Foramen Ovale: Echocardiographic Correlates of Stroke/TIA and Mortality.

Authors:  Shiva P Ponamgi; Vaibhav R Vaidya; Christopher V Desimone; Amit Noheria; David O Hodge; Joshua P Slusser; Naser M Ammash; Charles J Bruce; Alejandro A Rabinstein; Paul A Friedman; Samuel J Asirvatham
Journal:  Pacing Clin Electrophysiol       Date:  2017-02-07       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.